Randomized control trial

OP0246 ROMOSOZUMAB VERSUS DENOSUMAB IN HIGH-RISK PATIENTS WITH GLUCOCORTICOID-INDUCED OSTEOPOROSIS: A PILOT RANDOMIZED CONTROLLED TRIAL
C. C. Mok, W. H. MA, K. L. Chan, L. Y. Ho, S. M. Tse, S. Chen

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 164; DOI: 10.1136/annrheumdis-2023-eular.3195
LB0005 Rituximab Objective Outcome measures Trial in SLE (ROOTS): A double-blind randomised placebo-controlled feasibility trial
K. Mahmoud, M. Wilson, M. Y. MD Yusof, S. Brown, E. Hensor, E. Vital

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 202; DOI: 10.1136/annrheumdis-2023-eular.7022
OP0249 IS PREVENTION BETTER THAN CURE? DATA FROM A MONOCENTRIC RANDOMIZED CLINICAL TRIAL TO PREVENT ACUTE PHASE REACTION RELATED TO INTRAVENOUS BISPHOSPHONATES
R. DI Taranto, C. Crotti, A. Amati, F. Zucchi, R. Caporali, M. Varenna

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 165; DOI: 10.1136/annrheumdis-2023-eular.4091
OP0295 A 12-WEEK, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2B STUDY OF SAFETY, TOLERABILITY AND EFFICACY OF AR882 IN GOUT PATIENTS
J. C. C. Wei, R. M. Fleischmann, S. Morris, E. Polvent, Z. Shen, A. Clouser Roche, V. Hingorani, S. Yan, L. T. Yeh, R. Keenan

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 192; DOI: 10.1136/annrheumdis-2023-eular.3251
AB1696 COMPARISON OF THE EFFECTIVENESS OF THE PERSONALIZED SCHROTH EXERCISE AND CONVENTIONAL THERAPY FOR SCOLIOSIS IN CHILDREN WITH RHEUMATIC DISEASE
E. P. Kisa, E. Tarakci, G. Leblebici, M. Cacan, O. Kasapcopur

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 2086; DOI: 10.1136/annrheumdis-2023-eular.5042
OP0047 WITHDRAWAL OF MAINTENANCE GLUCOCORTICOID VERSUS OTHER IMMUNOSUPPRESSANTS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN LONG TERM CLINICAL REMISSION: INTERIM ANALYSIS OF A NON-INFERIORITY RANDOMISED CONTROLLED TRIAL
A. Gopal, C. Kavadichanda, M. Thabah, C. Mariaselvam, V. Negi

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 30-31; DOI: 10.1136/annrheumdis-2023-eular.4577
OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY
X. Baraliakos, M. Østergaard, D. Poddubnyy, D. Van der Heijde, A. Deodhar, P. Machado, V. Navarro-Compán, K. G. Hermann, M. Kishimoto, E. Y. Lee, L. S. Gensler, U. Kiltz, M. Eigenmann, P. Pertel, A. Readie, H. Richards, B. Porter, J. Braun

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 38-40; DOI: 10.1136/annrheumdis-2023-eular.301
POS0516 PERFORMANCE OF NURSE-LED GOUT CARE IN A PRIVATE HEALTHCARE SYSTEM. A RANDOMISED CONTROLLED TRIAL
B. Ankli, N. Miehe, D. Kyburz, N. Daikeler, B. Bannert, T. Daikeler

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 521; DOI: 10.1136/annrheumdis-2023-eular.3051
OP0143 EFFICACY AND SAFETY OF DAZODALIBEP (VIB4920/HZN4920) IN SUBJECTS WITH SJÖGREN’S SYNDROME: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY
E. W. St, Clair, L. Wang, I. Alevizos, W. Rees, A. Baer, W. F. Ng, G. Noaiseh, C. Baldini

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 95; DOI: 10.1136/annrheumdis-2023-eular.234
POS1310 FECAL MICROBIOTA TRANSPLANTATION IN PATIENTS WITH SYSTEMIC SCLEROSIS AND LOWER GASTROINTESTINAL TRACT SYMPTOMS: DATA FROM THE RESSCUE RANDOMIZED CLINICAL TRIAL
H. Fretheim, I. Barua, M. N. Carstens, H. Didriksen, V. Sarna, K. E. Lundin, O. Distler, D. Khanna, E. Volkmann, Ø. Midtvedt, T. Midtvedt, A. Dhainaut, A. K. H. Halse, G. Bakland, I. Olsen, M. E. Pesonen, Ø. Molberg, A. M. Hoffmann-Vold

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1004; DOI: 10.1136/annrheumdis-2023-eular.1880

Main menu

Randomized control trial

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Randomized control trial

Pages